Eton Pharmaceuticals, INC.
At a glance
Employees20-99
In business sinceNot reported
HeadquartersDeer Park, IL
US patents5
SAM.gov UEIRCDELCHESD49
CAGE code85RB4
Incorporated inDE
- therapies
- rare diseases
- Betaine Anhydrous
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
5 US patents granted 2017–2025, 4 of them in the five years to SEP 2025.
Pharmaceuticals 5
- Hydrocortisone oral liquid formulationsUS 12,419,831 · granted SEP 23, 2025
- Hydrocortisone oral liquid formulationsUS 12,133,914 · granted NOV 5, 2024
- Hydrocortisone oral liquid formulationsUS 11,904,046 · granted FEB 20, 2024
- More potent and less toxic formulations of epinephrine and methods of medical useUS 11,266,611 · granted MAR 8, 2022
- Pharmaceutical formulations of xanthine or xanthine derivatives, and their useUS 9,849,133 · granted DEC 26, 2017
Granted to Eton Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Eton Pharmaceuticals, INC. | Deer Park | IL | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.